CellMax Life Stock

CellMax Life is a biotechnology company that is focused on developments in early cancer detection and prevention.

Sign up today and learn more about CellMax Life Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About CellMax Life Stock

CellMax Life is a biotechnology company that is revolutionizing early cancer detection and prevention. The company’s product portfolio includes a blood test that can detect cancer before it is too late. CellMax Life was founded in 2013 and is based in California, United States. The company has offices in Silicon Valley (U.S.) and Taiwan, and is funded by a venture capital firm in the U.S. and technology industrialists in Taiwan.

Funding History

June 2013	$5.0M
July 2016	$9.0M

Management

Board Member

Amit Shah

Co-Founder

Ying-Chih Chang

Board Member

Akhil Saklecha

Co-Founder & CEO

Atul Sharan

Press

prweb - Aug, 4 2023

CellMax Life Appoints Dr. Ross D. “Rusty” Segan to Advisory Board

genomeweb - Apr, 8 2023

People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDx

news-medical - Jul, 28 2018

Opinion

prweb - Jun, 6 2018

CellMax Life’s Early Cancer Detection Platform Wins 2018 MedTech Breakthrough Award

prnewswire - May, 30 2018

CellMax Life Launches Zenith, a U.S. Clinical Study for the Advancement of Blood Tests for Early Cancer Detection, With the Goal of Seeking FDA Approval

Trending Companies

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Join Now

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen Inc. was awarded a 2023 Fintech Breakthrough Award by Tech Breakthrough LLC on or about March 23, 2023, based on the prior calendar year and covering calendar year 2023, and has compensated Tech Breakthrough LLC for use of its name and logo in connection with the award. Tech Breakthrough LLC is a third party and has no affiliation with EquityZen.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2024 EquityZen Inc. All rights reserved.